GSK-1940029

N/A

Report date: 2024/12/11 14:40:01
NME

Base Information

Drug NameGSK-1940029
Drug Alias NameGSK-1940029
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl-CoA desaturase inhibitors
TargetsAcyl-CoA desaturase
Therapy Area/IndicationsAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAcne Vulgaris

Other Information

ATC CodeN/A
Related LinksN/A